Kellanova: W.K. Kellogg entities report 13.0% stake in 13G/A
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
W.K. Kellogg Foundation Trust and W.K. Kellogg Foundation filed Amendment No. 49 to Schedule 13G reporting their beneficial ownership in Kellanova (K).
As of September 30, 2025, they beneficially own 45,097,438 shares of Kellanova common stock, representing 13.0% of the class, based on 347,669,200 shares outstanding as of June 28, 2025 as cited from the company’s Form 10‑Q. The filing lists shared voting power over 45,097,438 shares and shared dispositive power over 45,097,438 shares, with no sole voting or dispositive power.
The Trust’s current individual trustees are Steven A. Cahillane, La June Montgomery Tabron, and Richard M. Tsoumas. Under the Trust agreement, if trustees cannot reach a majority decision (including the corporate trustee), the Foundation may direct the vote, and it can approve successor trustees and remove trustees subject to limits; therefore, the Foundation may be deemed to beneficially own the shares.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Kellanova (K) is reported in this Schedule 13G/A?
Why may the W.K. Kellogg Foundation be deemed a beneficial owner?
Who are the current individual trustees of the Trust?
What is the amendment number and event date for this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.